Literature DB >> 23244574

HIV-positive status disclosure among men and women receiving antiretroviral treatment in eastern Ethiopia.

Ayalu A Reda1, Sibhatu Biadgilign, Kebede Deribe, Amare Deribew.   

Abstract

Disclosure of HIV infection status is a difficult process that involves communication of information about a potentially stigmatizing and transmissible illness. Despite this it is important for preventing HIV infection and mitigating its impacts. This study aims to describe disclosure of HIV diagnosis and factors associated with it among a cohort of patients receiving antiretroviral treatment in eastern Ethiopia. A descriptive study was conducted among a random sample of patients that started antiretroviral treatment in three hospitals located in eastern Ethiopia. Unadjusted and adjusted logistic regression models were used to examine association and derive odds ratios (OR) as well as 95% confidence intervals. A total of 1540 study participants were included in the study, where 963 (62.5%) were females and 574 (37.3%) males. Most of the married participants have disclosed to their wife or husband (402, 66.3%), but the overall sample had much lower rates of disclosure to brothers or sisters (262, 17.0%), and relatives (259, 16.8%). A small number of patients (11.6%, 179) did not disclose their infection status at all and none of the patients (0, 0%) had disclosed to all of their family members. In the multivariate logistic regression analysis patients who were not married (OR 1.54; 95% CI 1.01-2.35) and illiterate (OR 1.81; 95% CI 1.03-3.20) had higher odds of nondisclosure. The findings of the study revealed a lower level of HIV disclosure status compared to similar settings. Therefore, more focus should be given to unmarried and illiterate persons during counseling sessions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23244574     DOI: 10.1080/09540121.2012.748868

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  7 in total

1.  Disclosure History Among Persons Initiating Antiretroviral Treatment at Six HIV Clinics in Oromia, Ethiopia, 2012-2013.

Authors:  Tsigereda Gadisa; Olga Tymejczyk; Sarah Gorrell Kulkarni; Susie Hoffman; Maria Lahuerta; Robert H Remien; Muluneh Yigzaw; Shalo Daba; Batya Elul; Denis Nash; Zenebe Melaku
Journal:  AIDS Behav       Date:  2017-01

2.  Prevalence, patterns, and correlates of HIV disclosure among TB-HIV patients initiating antiretroviral therapy in Lesotho.

Authors:  Eleanor Hayes-Larson; Yael Hirsch-Moverman; Suzue Saito; Koen Frederix; Blanche Pitt; Bridget Llang Maama; Andrea A Howard
Journal:  AIDS Care       Date:  2017-01-18

3.  Human immunodeficiency virus positive status disclosure to a sexual partner and its determinant factors in Ethiopia: a systematic review and meta-analysis.

Authors:  Fikadu Yehualashet; Eleni Tegegne; Mekbib Tessema; Mulualem Endeshaw
Journal:  BMC Infect Dis       Date:  2020-05-29       Impact factor: 3.090

4.  Disclosure of HIV seropositivity to sexual partner in Ethiopia: A systematic review.

Authors:  Aklilu Endalamaw; Yibeltal Assefa; Demeke Geremew; Habte Belete; Berihun Assefa Dachew; Amare Belachew; Worku Animaw; Tesfa Dejenie Habtewold; Rhonda Wilson
Journal:  Womens Health (Lond)       Date:  2021 Jan-Dec

5.  Gender perspective of risk factors associated with disclosure of HIV status, a cross-sectional study in Soweto, South Africa.

Authors:  Elisa Longinetti; Michele Santacatterina; Ziad El-Khatib
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

6.  Reliability of reporting of HIV status and antiretroviral therapy usage during verbal autopsies: a large prospective study in rural Malawi.

Authors:  Estelle M Mclean; Menard Chihana; Themba Mzembe; Olivier Koole; Lackson Kachiwanda; Judith R Glynn; Basia Zaba; Moffat Nyirenda; Amelia C Crampin
Journal:  Glob Health Action       Date:  2016-06-09       Impact factor: 2.640

7.  Sero-positive HIV result disclosure to sexual partner in Ethiopia: a systematic review and meta-analysis.

Authors:  Fantahun Ayenew Mekonnen; Ayenew Molla Lakew; Kindie Fentahun Muchie; Destaw Fetene Teshome
Journal:  BMC Public Health       Date:  2019-12-27       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.